Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSeoul National University Hospital

About this trial

To evaluate the effect of accelerated atrial resynchronization achieved through Bachmann bundle pacing at the time of implantable cardioverter-defibrillator implantation in patients with heart failure with reduced ejection fraction and interatrial block

Eligibility criteria

Qualifiers

Age ≥18 years at the time of screening.

A documented diagnosis of chronic heart failure with New York Heart Association (NYHA) class II-IV.

Left ventricular ejection fraction (LVEF) ≤40%, documented by an imaging study performed within 12 months prior to screening.

Participants receiving ongoing treatment must be on a stable regimen for at least 1 month prior to screening (except for diuretics).

Disqualifiers

Non-paroxysmal AF.

Uncontrolled tachyarrhythmia.

Sinus bradycardia requiring continuous atrial pacing or atrioventricular block requiring ventricular pacing.

Acute decompensated heart failure at the time of screening or hospitalization for worsening heart failure within 4 weeks prior to enrollment.

Trial design

Treatments tested in this trial

  • BBAP on
  • BBAP off
  • RAAP

Treatment groups

120 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators